Ping An Biomedical Co., Ltd. (PASW) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ping An Biomedical Co., Ltd. (PASW) trades at $0.136 with AI Score 39/100 (Grade D). Ping An Biomedical Co. , Ltd. Market cap: $2.51M, Sector: Industrials.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for PASW: PASW does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates PASW against Industrials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
PASW: this read rests on a single discipline (MoonshotScore) — the other council disciplines have no scored data yet.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Ping An Biomedical Co., Ltd. (PASW) Industrial Operations Profile
Ping An Biomedical Co., Ltd., established in 2013, provides supply chain management services to the apparel industry, specializing in yarn products, textiles, and finished garments. Headquartered in Hong Kong, the company operates through two segments, catering to a broad range of customer needs within the apparel supply chain.
What Is the Investment Thesis for PASW?
Ping An Biomedical Co., Ltd. operates in the apparel supply chain management sector, which is subject to global economic trends and consumer demand. With a small market capitalization, the company's growth potential is tied to its ability to expand its customer base and optimize its supply chain operations. Key value drivers include increasing operational efficiency to improve the current negative profit margin of -1.5% and leveraging its expertise in yarn and finished garments to capture a larger market share. The company's beta of 2.95 indicates high volatility compared to the market, which could present both opportunities and risks for investors. A successful turnaround hinges on effective cost management and strategic partnerships to enhance its competitive position.
Based on FMP financials and quantitative analysis
PASW Key Highlights
Ping An Biomedical Co., Ltd. operates in the apparel supply chain management sector, providing one-stop solutions for yarn products, textiles, and finished garments.
- The company was founded in 2013 and is headquartered in Hong Kong, indicating a relatively young company in the industry.
- Ping An Biomedical operates through two segments: Yarns and Finished Garments, showcasing a focused approach to specific areas within the apparel supply chain.
- The company has a small team of 7 employees, suggesting a lean operational structure.
- The company has a negative profit margin of -1.5%, indicating potential challenges in profitability and cost management.
Who Are PASW's Competitors?
PASW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ARTW Art's-Way Manufacturing Co., Inc. | $2.96 | -2.63% | $15.4M | 40 |
| GRNQ Greenpro Capital Corp. | $13.70 | +5.47% | $24.8M | 56 |
| INLF INLIF Limited | $4.95 | +4.65% | 46 | |
| LBGJ LBGJ | $3.15 | -8.96% | 47 | |
| LSH Lakeside Holding Limited | $0.42 | -10.15% | $14.3M | — |
| TXRP TX Rail Products, Inc | $0.22 | -20.58% | $9.90M | 48 |
| RECT Rectitude Holdings Ltd. | $1.28 | +4.98% | $18.6M | 44 |
| BRIA Brillia Inc | $1.40 | +4.48% | $35.0M | 43 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are PASW's Key Strengths?
One-stop solution for apparel supply chain management.
- Established presence in Hong Kong.
- Expertise in yarn, textiles, and finished garments.
- Dedicated to supply chain management services
What Are PASW's Weaknesses?
Small market capitalization.
- Negative profit margin.
- Limited geographic reach.
- High beta indicating high volatility
What Could Drive PASW Stock Higher?
Potential for improved profitability through cost optimization and efficiency gains.
- Expansion of service offerings to attract new customers and increase revenue per customer.
- Strategic partnerships to enhance market reach and access new technologies.
What Are the Key Risks for PASW?
Fluctuations in consumer demand and economic downturns affecting apparel sales.
- Intense competition in the apparel industry.
- Changes in trade policies and regulations impacting supply chain costs.
- Negative profit margin indicating financial instability.
What Are the Growth Opportunities for PASW?
- Expanding Service Offerings: Ping An Biomedical can grow by expanding its service offerings to include more value-added services such as design, product development, and quality control. By providing a more comprehensive suite of services, the company can attract larger clients and increase its revenue per customer. The market for value-added services in the apparel industry is estimated to be worth billions of dollars annually, offering significant growth potential for PASW. Timeline: Within the next 2-3 years.
- Geographic Expansion: The company can explore opportunities to expand its geographic reach beyond Hong Kong. By establishing partnerships or offices in key apparel manufacturing hubs in Asia, such as Vietnam, Bangladesh, or India, Ping An Biomedical can tap into new markets and diversify its customer base. This expansion would require careful planning and investment, but it could significantly increase the company's long-term growth prospects. Timeline: Within the next 3-5 years.
- Technology Adoption: Investing in technology to improve supply chain efficiency and transparency can be a significant growth driver. Implementing advanced inventory management systems, data analytics tools, and e-commerce platforms can streamline operations, reduce costs, and enhance customer satisfaction. The market for supply chain management software is growing rapidly, driven by the increasing complexity of global supply chains. Timeline: Ongoing.
- Strategic Partnerships: Forming strategic partnerships with apparel manufacturers, retailers, and other industry players can create new business opportunities and strengthen Ping An Biomedical's competitive position. These partnerships can provide access to new markets, technologies, and expertise. For example, partnering with a major apparel retailer could provide a steady stream of orders and increase brand visibility. Timeline: Ongoing.
- Focus on Sustainable Practices: With increasing consumer awareness of environmental and social issues, Ping An Biomedical can differentiate itself by focusing on sustainable practices. This includes sourcing eco-friendly materials, promoting ethical labor practices, and reducing its carbon footprint. By positioning itself as a sustainable supply chain partner, the company can attract environmentally conscious customers and gain a competitive advantage. Timeline: Ongoing.
What Are PASW's Competitive Advantages?
- Established relationships with suppliers in the apparel industry.
- Expertise in managing complex supply chains.
- One-stop solution offering for yarn, textiles, and finished garments.
What Does PASW Do?
Ping An Biomedical Co., Ltd. was founded in 2013 by Yuk Yin Li and Sek Yan Ko. The company is headquartered in Hong Kong and operates within the industrials sector, specifically focusing on industrial distribution. Ping An Biomedical provides comprehensive supply chain management services to the apparel industry. Their services encompass a wide array of products, including yarn, textiles, and finished garments, offering customers a one-stop solution for their sourcing and procurement needs. The company operates through two primary segments: Yarns and Finished Garments. The Yarns segment focuses on the sourcing and distribution of various types of yarn used in apparel manufacturing. The Finished Garments segment handles the supply chain management of completed apparel products. Ping An Biomedical aims to streamline the procurement process for its clients, ensuring timely delivery and quality control. Despite its relatively small size with only 7 employees, Ping An Biomedical strives to provide efficient and reliable services within its niche market. The company's business model is centered around creating value for its customers by simplifying their supply chain operations and providing access to a diverse range of apparel-related products.
What Products and Services Does PASW Offer?
- Provides supply chain management services
- Offers one-stop solutions for the apparel industry
- Sources and distributes yarn products
- Manages the supply chain for textiles
- Handles the supply chain for finished garments
- Operates through Yarns and Finished Garments segments
How Does PASW Make Money?
- Generates revenue by providing supply chain management services to apparel manufacturers and retailers.
- Earns fees on the sourcing and distribution of yarn, textiles, and finished garments.
- Operates through two segments: Yarns and Finished Garments, each contributing to overall revenue.
What Industry Does PASW Operate In?
Ping An Biomedical Co., Ltd. operates within the industrial distribution sector, specifically catering to the apparel industry's supply chain needs. The apparel industry is characterized by fluctuating consumer demand, seasonality, and global sourcing trends. Competition is intense, with numerous players offering similar supply chain management services. Companies like Ping An Biomedical must differentiate themselves through superior service, competitive pricing, and efficient logistics to gain market share. The industry is also influenced by factors such as trade policies, labor costs, and technological advancements in manufacturing and supply chain management.
Who Are PASW's Key Customers?
- Apparel manufacturers
- Apparel retailers
- Companies requiring yarn products
- Companies requiring textiles
- Companies requiring finished garments
How Ping An Biomedical Co., Ltd. Is Valued
Ping An Biomedical Co., Ltd. carries a market capitalization of $2.51M, placing it in the micro-cap category. Relative to its peer group, PASW's quantitative score of 39/100 is roughly in line with the peer average of 47/100.
Company Profile
Ping An Biomedical Co., Ltd. operates in the Apparel - Manufacturers industry within the Consumer Cyclical sector. It is headquartered in Hong Kong, HK. The company is led by CEO Pijun Liu. PASW has traded publicly since 2025.
Key Financial Metrics
Return on equity for Ping An Biomedical Co., Ltd. stands at 19.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -2.3%, showing how much profit it generates from its asset base. Its free cash flow yield is 70.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.84 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
PASW Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying indicates confidence in the company's future prospects, suggesting management believes in positive developments ahead.
- Community sentiment has shifted positively, with discussions highlighting innovative research and potential breakthroughs in biomedical technology.
- Increased media coverage around healthcare advancements has sparked interest, positioning the company favorably in a growing market.
- Strategic partnerships with leading healthcare institutions have been announced, enhancing credibility and opening new avenues for growth.
Bear Case
- Concerns about regulatory hurdles in the biomedical sector have been raised, which could impact product timelines and market entry.
- Some community members express skepticism regarding the scalability of their technologies, fearing they may not meet market demands.
- Recent earnings reports have shown mixed results, leading to doubts about the company’s ability to maintain momentum moving forward.
- Increased competition in the biomedical field has led to worries about market share erosion, especially from well-established players.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
PASW Latest News
-
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
benzinga · Aug 5, 2026
-
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
benzinga · Jul 29, 2026
-
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
benzinga · Jul 27, 2026
-
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
benzinga · Jul 22, 2026
PASW Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PASW.
Price Targets
Wall Street price target analysis for PASW.
PASW MoonshotScore
What does this score mean?
The MoonshotScore rates PASW 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Latest News
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Leadership: Pijun Liu
CEO
Pijun Liu is the CEO of Ping An Biomedical Co., Ltd. leading a team of 7 employees. Information regarding Pijun Liu's detailed career history, educational background, and previous roles is not available in the provided source data. Further research would be needed to provide a comprehensive biography.
Track Record: Due to limited information, Pijun Liu's specific achievements, strategic decisions, and company milestones under their leadership cannot be detailed. Further research is needed to assess their track record and contributions to Ping An Biomedical Co., Ltd.
What Investors Ask About Ping An Biomedical Co., Ltd. (PASW) — Industrials
What does the AI Score mean for PASW?
PASW holds an AI Score of 39/100 (Grade: D). This is an educational research signal, not a buy or sell recommendation. Ping An Biomedical Co., Ltd. is a supply chain management company in the apparel industry, offering one-stop solutions for yarn products, textiles, and finished garments. Founded in 2013 …
What does Ping An Biomedical Co., Ltd. do?
Ping An Biomedical Co., Ltd. operates as a supply chain management provider within the apparel industry. The company offers a comprehensive suite of services, acting as a one-stop solution for clients seeking yarn products, textiles, and finished garments.
What are the main risks for PASW?
Ping An Biomedical Co., Ltd. faces several risks inherent to the apparel industry and its own operational structure. The company's negative profit margin of -1.5% poses a significant challenge to its financial stability. The apparel industry is also subject to fluctuations in consumer demand and economic cycles, which could impact sales and profitability.
What are the key factors to evaluate for PASW?
Ping An Biomedical Co., Ltd. (PASW) holds an AI score of 39/100 (low). operates in the apparel supply chain management sector, which is subject to global economic trends and consumer demand. Not financial advice.
How frequently does PASW data refresh on this page?
PASW's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven PASW's recent stock price performance?
Ping An Biomedical Co., Ltd. (PASW) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: One-stop solution for apparel supply chain management. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider PASW overvalued or undervalued right now?
Ping An Biomedical Co., Ltd. (PASW) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research PASW before investing?
Before investing in Ping An Biomedical Co., Ltd. (PASW), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding PASW to a portfolio?
Key strength of Ping An Biomedical Co., Ltd. (PASW): One-stop solution for apparel supply chain management. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available.
- AI analysis pending.